13F filerCIK 1536411 ↗

Duquesne Family Office

You are looking at Q4 2022. See the latest, Q3 2026 →

Reported value

$2.02B

+15% on the quarter before

Positions

58

16 new, 23 sold out

Top 10

68.7%

of the value

Est. gain

+$65.8M

on stocks held all quarter

Est. return

+5.6%

on those stocks since Q3 2022

Filed

Feb 14, 2023

On SEC EDGAR ↗

Positions as of Dec 31, 2022, from Duquesne Family Office's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2022. Striped tiles are options.

Coupang Inc15%
Eli Lilly13%
34 others11%
Chevron Corp New8.7%
Lamb Weston Hldgs Inc7.3%
Meta5.4%
Kbr Inc4.4%
Nvidia4.2%Vertiv4.0%
Teck Resources Ltd3.3%
T-Mobile Us Inc3.1%
Cenovus Energy Inc2.6%
Option Care Health Inc2.3%
Lennar Corp2.0%
Freeport-McMoRan1.6%
Deere & Co1.5%
Occidental Pete Corp1.3%
Natera Inc1.3%
AT&T1.3%Datadog1.2%
Alnylam Pharmaceuticals Inc1.0%
Ovintiv Inc1.0%
AMD1.0%
Parker-Hannifin Corp1.0%
Arch Resources Inc0.9%

Largest buys

Since Q3 2022, sized at quarter-end prices.

  1. Eli Lilly~$92.5MAdded, 8.9% → 13.4% of the portfolio+252,830 shares
  2. Meta~$89.2MAdded, 1.2% → 5.4% of the portfolio+741,315 shares
  3. Nvidia~$85.2MNew, 0.0% → 4.2% of the portfolio+582,915 shares
  4. Lamb Weston Hldgs Inc~$63.5MAdded, 4.2% → 7.3% of the portfolio+711,075 shares
  5. Chevron Corp New~$52.7MAdded, 5.6% → 8.7% of the portfolio+293,360 shares
  6. Lennar Corp~$40.0MNew, 0.0% → 2.0% of the portfolio+441,892 shares
  7. Option Care Health Inc~$36.5MAdded, 0.6% → 2.3% of the portfolio+1,214,020 shares
  8. Cenovus Energy Inc~$36.2MAdded, 0.7% → 2.6% of the portfolio+1,863,295 shares
  9. Deere & Co~$31.3MNew, 0.0% → 1.5% of the portfolio+72,905 shares
  10. Occidental Pete Corp~$26.5MNew, 0.0% → 1.3% of the portfolio+420,580 shares

Largest sells

Since Q3 2022, sized at quarter-end prices.

  1. Amazon~$102.4MSold out, 5.8% → 0.0% of the portfolio−906,250 shares
  2. Microsoft~$45.1MSold out, 2.6% → 0.0% of the portfolio−193,535 shares
  3. T-Mobile Us Inc~$37.1MCut, 5.5% → 3.1% of the portfolio−264,655 shares
  4. Workday~$36.7MSold out, 2.1% → 0.0% of the portfolio−240,925 shares
  5. Datadog~$33.6MCut, 4.0% → 1.2% of the portfolio−456,922 shares
  6. Sea~$30.3MSold out, 1.7% → 0.0% of the portfolio−539,740 shares
  7. Willscot Mobil Mini Hldng Co~$30.2MCut, 2.2% → 0.7% of the portfolio−667,765 shares
  8. Coterra Energy Inc~$29.1MSold out, 1.7% → 0.0% of the portfolio−1,113,900 shares
  9. CrowdStrike~$25.3MSold out, 1.4% → 0.0% of the portfolio−153,524 shares
  10. Ppg Inds Inc~$23.6MSold out, 1.3% → 0.0% of the portfolio−212,945 shares

Holdings

As of Dec 31, 2022; changes in shares since Sep 30, 2022.

Positions, sorted by share of the portfolio
HoldingValue
Coupang IncCL A · shares +4.4% · price −11.8%14.8%$298.4M−$38.1M
Eli LillyCOM · shares +52% · price +13.1%13.4%$269.9M+$20.6M
Chevron Corp NewCOM · shares +42% · price +24.9%8.7%$176.6M+$24.7M
Lamb Weston Hldgs IncCOM · shares +75% · price +15.5%7.3%$148.1M+$11.3M
MetaCL A · shares +462% · price −11.3%5.4%$108.5M−$2.5M
Kbr IncCOM · shares −7.1% · price +22.2%4.4%$89.1M+$16.2M
NvidiaCOM · shares New4.2%$85.2M—
VertivCOM CL A · shares +20% · price +40.5%4.0%$80.8M+$19.4M
Teck Resources LtdCL B · shares +30% · price +24.4%3.3%$67.3M+$10.2M
T-Mobile Us IncCOM · shares −37% · price +4.3%3.1%$63.6M+$2.6M
Cenovus Energy IncCOM · shares +222% · price +26.3%2.6%$52.4M+$3.4M
Option Care Health IncCOM NEW · shares +389% · price −4.4%2.3%$45.9M−$430,911
Lennar CorpCL A · shares New2.0%$40.0M—
Freeport-McMoRanCL B · shares −28% · price +39.0%1.6%$31.8M+$8.9M
Deere & CoCOM · shares New1.5%$31.3M—
Occidental Pete CorpCOM · shares New1.3%$26.5M—
Natera IncCOM · shares +55% · price −8.3%1.3%$25.9M−$1.5M
AT&TCOM · shares New1.3%$25.3M—
DatadogCL A COM · shares −58% · price −17.2%1.2%$24.4M−$5.1M
Alnylam Pharmaceuticals IncCOM · shares 0% · price +18.7%1.0%$21.1M+$3.3M
Ovintiv IncCOM · shares +113% · price +10.2%1.0%$21.0M+$913,825
AMDCOM · shares New0.99%$20.0M—
Parker-Hannifin CorpCOM · shares New0.96%$19.4M—
Arch Resources IncCL A · shares −13% · price +20.4%0.91%$18.4M+$3.1M
Vale S ASPONSORED ADS · shares New0.88%$17.7M—
Total 58 positions100%$2.02B+$65.8M

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q3 2022 to Q4 2022: 41 stocks held throughout, up $65.8M (+5.6%).

  1. Chevron Corp New+$24.7M+25%
  2. Eli Lilly+$20.6M+13%
  3. Vertiv+$19.4M+41%
  4. Kbr Inc+$16.2M+22%
  5. Lamb Weston Hldgs Inc+$11.3M+15%
  6. Enovix Corporation−$2.7M−32%
  7. Opendoor Technologies Inc−$3.0M−63%
  8. Recursion Pharmaceuticals In−$4.1M−28%
  9. Datadog−$5.1M−17%
  10. Coupang Inc−$38.1M−12%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

Pick a quarter to see what the fund held then.

$6.00B$3.00B$0
Q1 2016Q3 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q3 2026$4.47B−14%SEC ↗
Q2 2026$5.21B+54%SEC ↗
Q1 2026$3.38B−25%SEC ↗
Q4 2025$4.49B+11%SEC ↗
Q3 2025$4.06B−0%SEC ↗
Q2 2025$4.07B+33%SEC ↗
Q1 2025$3.06B−18%SEC ↗
Q4 2024$3.72B+26%SEC ↗
Q3 2024$2.95B+1%SEC ↗
Q2 2024$2.92B−34%SEC ↗
Q1 2024$4.39B+31%SEC ↗
Q4 2023$3.35B+20%SEC ↗
Q3 2023$2.79B−3%SEC ↗
Q2 2023$2.87B+25%SEC ↗
Q1 2023$2.31B+14%SEC ↗
Q4 2022$2.02B+15%SEC ↗
Q3 2022$1.76B+28%SEC ↗
Q2 2022$1.38B−40%SEC ↗
Q1 2022$2.31B−16%SEC ↗
Q4 2021$2.76B−10%SEC ↗
Q3 2021$3.08B−24%SEC ↗
Q2 2021$4.04B−11%SEC ↗
Q1 2021$4.53B+22%SEC ↗
Q4 2020$3.71B+8%SEC ↗
Q3 2020$3.44B+5%SEC ↗
Q2 2020$3.27B+32%SEC ↗
Q1 2020$2.47B−28%SEC ↗
Q4 2019$3.41B+33%SEC ↗
Q3 2019$2.57B−24%SEC ↗
Q2 2019$3.37B−2%SEC ↗
Q1 2019$3.45B+100%SEC ↗
Q4 2018$1.73B−18%SEC ↗
Q3 2018$2.10B+2%SEC ↗
Q2 2018$2.07B+14%SEC ↗
Q1 2018$1.81B−9%SEC ↗
Q4 2017$1.98B−10%SEC ↗
Q3 2017$2.20B+18%SEC ↗
Q2 2017$1.87B+22%SEC ↗
Q1 2017$1.52B+49%SEC ↗
Q4 2016$1.03B−9%SEC ↗
Q3 2016$1.13B+30%SEC ↗
Q2 2016$870.7M−35%SEC ↗
Q1 2016$1.34BSEC ↗

Subscribe to TheInference for free